Ottawa signs $40M deal with Saskatchewan to offer drug coverage for rare diseases

By Staff The Canadian Press

Posted January 10, 2025 5:25 pm

Updated January 10, 2025 7:03 pm

1 min read

If you get Global News from Instagram or Facebook - that will be changing. Find out how you can still connect with us.

Click to play video: 'Saskatchewan to receive federal funding for rare disease medicine' — Thousands of Canadians live everyday with rare conditions, and they often struggle to access costly, life-saving medications. But as Nicole Healey explains, that's about to change in Saskatchewan – Jan 10, 2025

The Saskatchewan and federal governments have announced an agreement for coverage of select new drugs for rare diseases.

Ottawa says the plan is to invest more than $40 million to cover three drugs that treat certain cancers and a urinary issue.

Get weekly health news

Receive the latest medical news and health information delivered to you every Sunday.

By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.

The medicines are Poteligeo, Oxlumo and Epkinly.

The agreement is to also see Saskatchewan work with Ottawa and other provinces to develop a plan to improve screening and diagnostics for rare diseases.

Federal Health Minister Mark Holland says the deal helps the health system improve outcomes for those in Saskatchewan with rare diseases.

Stick to the Facts

Add Global News as a Preferred Source on Google to see more of our stories in your search results.

Journalistic standards Report an error

Menu

Topics

TV Programs

Connect

Local

your local region

Share

Calendar

Calendar

Search

Quick Search

Add Global News to Home Screen

Comments